R. Penland

Magnetic resonance myocardial fiber-orientation mapping with direct histological correlation.

C. Henriquez, E. Hsu, A. L. Muzikant, 1998, American journal of physiology. Heart and circulatory physiology.

Premature beats undergo transmural conduction slowing due to intrinsic APD dispersion

C. Henriquez, R. Penland, K. Sampson, 1999, Proceedings of the First Joint BMES/EMBS Conference. 1999 IEEE Engineering in Medicine and Biology 21st Annual Conference and the 1999 Annual Fall Meeting of the Biomedical Engineering Society (Cat. N.

Modeling impulse propagation and extracellular potential distributions in anisotropic cardiac tissue using a finite volume element discretization

C. Henriquez, R. Penland, D. Harrild, 2002 .

Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.

G. Helmlinger, R. Penland, A. Stamps, 2006, Progress in biophysics and molecular biology.

Novel Orally Swallowable IntelliCap® Device to Quantify Regional Drug Absorption in Human GI Tract Using Diltiazem as Model Drug

R. Penland, T. Heimbach, J. Shimizu, 2014, AAPS PharmSciTech.

Systems Toxicology Modeling for Prediction in Humans

G. Helmlinger, R. Penland, T. Lavé, 2011 .

Renal Effects of Dapagliflozin in People with and without Diabetes with Moderate or Severe Renal Dysfunction: Prospective Modeling of an Ongoing Clinical Trial

G. Helmlinger, R. Penland, H. Heerspink, 2020, The Journal of Pharmacology and Experimental Therapeutics.

Magnetic resonance myocardial fiber-orientation mapping with direct histological correlation.

C. Henriquez, E. Hsu, A. L. Muzikant, 1998, The American journal of physiology.

Models for profiling the potential QT prolongation risk of drugs.

A. L. Muzikant, R. Penland, Adam L Muzikant, 2002, Current opinion in drug discovery & development.

Novel Orally Swallowable IntelliCap® Device to Quantify Regional Drug Absorption in Human GI Tract Using Diltiazem as Model Drug

R. Penland, T. Heimbach, J. Shimizu, 2014, AAPS PharmSciTech.

Cardiac Safety Implications of hNav1.5 Blockade and a Framework for Pre-Clinical Evaluation

R. Penland, G. Erdemli, C. Springer, 2012, Front. Pharmacol..

Using in silico biology to facilitate drug development.

R. Penland, A. Stamps, R Christian Penland, 2002, Novartis Foundation symposium.

A flexible method for simulating cardiac conduction in three-dimensional complex geometries.

R. Penland, D. Harrild, Craig S. Henriquez, 2000, Journal of electrocardiology.